Total Company Value: iobiotech.com (IOBT)

IO Biotech Inc. (IOBT) - corporate logo

IO Biotech, Inc. (IOBT) is implementing robotic systems to accelerate peptide analysis for cancer vaccine development, eliminating monotonous labor for scientists. The firm's strategy relies on patenting immunotherapeutic discoveries and maintaining long-term alliances with pharmaceutical behemoths. This Enterprise Value chart is fixed at -9.09. The company is currently completing the final stage of trials for its melanoma drug, paving the way for a full-scale product market launch.

IOBT (IO Biotech, Inc.) Total Company Value history from 11/23/2025 to 04/11/2026

IO Biotech, Inc. - analytical breakdowns and key metrics (IOBT)

- price and consensus price forecast:
Market Price IO Biotech Inc|IOBT - Analyst Consensus Forecast
- market capitalization data:
Market Value IO Biotech|IOBT - Real Price to Acquire Entire Company
- book capitalization data:
Book Price of a Share IO Biotech|IOBT - Company Book Value|Market-to-Book Ratio iobiotech.com|IOBT - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Ratio IO Biotech, Inc.|IOBT - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio iobiotech.com|IOBT - Company Debts|Debts to Book Value IO Biotech
Fundamental valuation:IO Biotech Inc (IOBT)
Original product of IO Biotech

Enterprise Value (EV) represents the sum of market capitalization and net debt, reflecting the actual cost of a full business buyout minus liquid assets. For IO Biotech, Inc. (IOBT), where the reputational capital of Danish management ensures efficient resource management, the company's aggregate asset valuation allows for an objective correlation between the value of the clinical pipeline and real financial obligations.

Competitors of IO Biotech, Inc. (IOBT)

Total Enterprise Value ImmunityBio Inc IBRX|IMCR - Enterprise Value|Janux Corp (JANX) - Total Company Value|RCUS - Real Price to Acquire Entire Company|ZYME (zymeworks.com) - Aggregate Business Value|Total Company Value TNGX (Tango Therapeutics, Inc.)|Total Enterprise Value IOVA|Total Company Value Immatics Corp IMTX|Business Value Xencor Inc. (XNCR)|Compass Therapeutics - Enterprise Value|replimune.com - Real Price to Acquire Entire Company|LYEL (Lyell Immunopharma, Inc.) - Total Company Value|IPHA: Total Enterprise Value|pyxisoncology.com (PYXS) - Total Company Value|CGEN (Compugen) - Total Company Value|Total Company Value STRO (Sutro Biopharma, Inc.)|Total Enterprise Value minktherapeutics.com|HOWL: Enterprise Value|Full Takeover Company Value immixbio.com IMMX|ALXO: Real Price to Acquire Entire Company|CUE - Total Enterprise Value|Real Price to Acquire Entire Company PDS Biotechnology Corp (PDSB)|SONN - Value Adjusted for Debt and Cash|MAIA Biotechnology, Inc. - Enterprise Value|LIMN (Liminatus Pharma Inc.) - Company Buyout Price|Total Company Value LVTX|Real Price to Acquire Entire Company NXTC|Total Company Value LPTX (Leap Therapeutics, Inc.)|Real Price to Acquire Entire Company intensitytherapeutics.com INTS|Real Price to Acquire Entire Company SNSE (Sensei Biotherapeutics, Inc.)|Theriva Biologics Inc - Enterprise Value|Gritstone Bio (GRTS) - Total Company Value|KA: Business Value|Total Company Value NEXI|Total Enterprise Value Turnstone Biologics Corp.|Vaccinex - Real Price to Acquire Entire Company|Full Takeover Company Value Harpoon Therapeutics Inc (HARP)